Self-Injectable Naloxone is Expected to Fueling Growth of the U.S. Naloxone Market

 

Naloxone is an opioid antagonist used to reverse opioid overdoses. It works by binding to opioid receptors and blocking the effects of other opioid drugs. It is widely administered via injection or nasal spray. Self-injectable forms provide easy access in emergency situations.

The global U.S. Naloxone Market is estimated to be valued at US$ 1,390.7 Mn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growing prevalence of opioid addiction and overdose deaths are driving the U.S. naloxone market. According to Centers for Disease Control and Prevention, nearly 50,000 individuals in the U.S. died due to opioid overdose in 2020. Rising awareness about overdose-reversing drugs and government initiatives to make naloxone more accessible without prescription are also fueling the market growth. In 2021, the FDA approved Hyloris' oral naloxone as the first non-injection drug to treat opioid overdose during emergency situations.
Segment Analysis

The U.S. naloxone market is segmented into auto-injectors, spray formulations, prefilled syringes, and others. Among these, auto-injectors dominate the market as they are easy-to-administer, single-use automated injection devices that require minimal training. Auto-injectors provide voice instructions for use, helping bystanders or even individuals at risk of overdose to deliver naloxone quickly during an emergency.

Key Takeaways

Market size
The global U.S. naloxone market is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing incidence of opioid overdose deaths.

Regional analysis
Regionally, the North-eastern region dominates the U.S. naloxone market due to higher prevalence of opioid use disorders. States like West Virginia, Ohio, Pennsylvania, Kentucky have the highest rates of opioid overdoses and related deaths.

Key players
Key players operating in the U.S. naloxone market are Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., Kern Pharma, S.L., Samarth Life Sciences Pvt. Ltd., Opiant Pharmaceuticals, Pfizer, Sandoz, and Amneal Pharmaceuticals.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more